NOTICE REGARDING THE AVAILABILITY OF ADMINISTRATIVE SUPPLEMENTS TO SUPPORT 
INTERNATIONAL COLLABORATIVE RESEARCH ON DRUG ABUSE

Release Date:  February 6, 2002
       
NOTICE:  NOT-DA-02-003

National Institute on Drug Abuse (NIDA)
 (http://www.nida.nih.gov)

PURPOSE

The National Institute on Drug Abuse (NIDA) announces the availability of 
funds to supplement existing NIDA-supported research projects to expand 
current research efforts, within the scope of the original grant, to conduct 
research in international sites. Funds will be provided through 
administrative supplements to take advantage of unique opportunities to 
support research in all areas of drug-abuse science.  Preference will be 
given to projects that are collaboratively funded by an agency of the host 
country.  Only existing R01 and R21 grants supported by NIDA with at least 
one year of support remaining at the time of the supplemental award are 
eligible for supplemental support under this notice. Supplements may be 
requested for up to 2 years of support, but extend no longer than the parent 
grant, with funding beginning no later than September 30, 2002.  For more 
information refer to http://www.drugabuse.gov/Funding/Internationalsupp.html.

INQUIRIES 

Inquiries concerning this notice are strongly encouraged.  The opportunity to 
clarify any issue or questions from potential applicants is welcome.

o Direct any questions about this notice to:

Steven Gust, Ph.D.
Acting Director, NIDA International Program 
National Institute on Drug Abuse
6001 Executive Boulevard, Room 5274, MSC 9581
Bethesda, MD  20892-9581
Telephone:  (301) 443-6480
Email:  sgust@nida.nih.gov

Return to Volume Index

Return to NIH Guide Main Index

	Office of Extramural Research (OER)			National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892			Department of Health and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, RealPlayer, Video or Flash files, see Help Downloading Files.